Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,130,813
Closed -$156M 118
2023
Q3
$156M Buy
4,130,813
+173,130
+4% +$7.05M 0.98% 19
2023
Q2
$161M Buy
3,957,683
+3,719,073
+1,559% +$154M 0.64% 21
2023
Q1
$10M Sell
238,610
-170,300
-42% -$7.1M 0.04% 170
2022
Q4
$17.7M Sell
408,910
-58,563
-13% -$2.31M 0.07% 107
2022
Q3
$17.5M Buy
467,473
+81,023
+21% +$3.58M 0.06% 103
2022
Q2
$17.5M Buy
386,450
+56,820
+17% +$2.67M 0.07% 98
2022
Q1
$15.7M Buy
+329,630
New +$14M 0.06% 108
2015
Q3
Sell
-41,684
Closed -$934K 223
2015
Q2
$934K Buy
+41,684
New +$999K ﹤0.01% 164

Other funds holding EXC

Brookfield Corp's EXC Position: Q4 2023 in Review

Brookfield Corp sold out of Exelon (EXC) in Q4 2023, closing a stake of 4,130,813 shares — an estimated $156M sold.

Brookfield Corp first reported a position in EXC in Q2 2015 and held it in 8 quarters. The position peaked at $161M in Q2 2023. 1,017 funds tracked by Wall St. Rank hold EXC as of Q4 2023.

  • Brookfield Corp reported no remaining Exelon position as of Q4 2023 after selling out during the quarter.
  • Brookfield Corp sold 4,130,813 Exelon shares in Q4 2023, an estimated $156M.
  • Brookfield Corp first reported a position in Exelon in Q2 2015 and held it in 8 quarters.
  • Brookfield Corp's Exelon position peaked at $161M in Q2 2023.
  • 1,017 funds tracked by Wall St. Rank held Exelon as of Q4 2023.

Based on Brookfield Corp's 13F filing for Q4 2023, filed 14 Feb 2024.